IL-22 has complex roles in gastric pathology, as it can promote epithelial regeneration and barrier function but also drive inflammation and hyperplasia; its dual effects in this model reflect the complexity of IL-22 signaling in human gastric diseases (Lindemans et al., 2015; Keir et al., 2020; Chen et al., 2014). This evidence concerns the gene IL22 and stomach disorder.